Ischaemic Preconditioning Protects Against Ischaemia/Reperfusion Injury: Emerging Concepts

AbstractIntroductionIschaemic preconditioning (IP) has emerged as a powerful method of ameliorating ischaemia/reperfusion (I/R) injury to the myocardium. This review investigates whether this phenomenon is universally applicable in modulating I/R injury to other tissues.MethodsA Medline search was conducted to identify both animal and human studies that described IP-induced protection from I/R injury in a variety of non-cardiac organ systems. Particular emphasis was placed on elucidation of underlying physiological concepts.Results and conclusionsIP utilises endogenous mechanisms in skeletal muscle, liver, lung, kidney, intestine and brain in animal models to convey varying degrees of protection from I/R injury. To date there are few human studies, but recent reports suggest that human liver, lung and skeletal muscle acquire similar protection after IP. Specifically, preconditioned tissues exhibit reduced energy requirements, altered energy metabolism, better electrolyte homeostasis and genetic re-organisation, giving rise to the concept of ‘ischaemia tolerance’. IP also induces ‘reperfusion tolerance’ with less reactive oxygen species and activated neutrophils released, reduced apoptosis and better microcirculatory perfusion compared to non-preconditioned tissue. Systemic I/R injury is also diminished by preconditioning. IP is ubiquitous but more research is required to fully translate these findings to the clinical arena

The Continuing Challenges of Translational Research: Clinician-Scientists’ Perspective

Over the last twenty years, revolutionary advances in biomedicine including gene therapy, stem cell research, proteomics, genomics and nanotechnology have highlighted the progressive need to restructure traditional approaches to basic and clinical research in order to facilitate the rapid, efficient integration and translation of these new technologies into novel effective therapeutics. Over the past ten years, funding bodies in the USA and UK such as the National Institutes of Health (NIH) and the Medical Research Council (MRC) have been driving translational research by defining and tackling the hurdles but more still remains to be achieved. This article discusses the ongoing challenges translational researchers face and outlines recent initiatives to tackle these including the new changes to translational funding schemes proposed by the NIH and the MRC and the launch of the "European Advanced Translational Research InfraStructure in Medicine" (EATRIS). It is anticipated that initiatives such as these will not only strengthen translational biomedical research programmes already initiated but should lead to rapid benefits to patients and society

A Global Challenge: Sustainability of Submicrometer PEO and PVP Fiber Production

The field of submicrometer polymeric production currently has a predominant research focus on morphology and application. In comparison, the sustainability of the manufacture of submicrometer polymeric fibers, specifically the energy efficiency, is less explored. The principles of Green Chemistry and Green Engineering outline frameworks for the manufacture of “greener” products, where the most significant principles in the two frameworks are shown to be centered on energy efficiency, material wastage, and the use of non-hazardous materials. This study examines the power consumption during the production of Polyethylene oxide (PEO) and Polyvinylpyrrolidone (PVP) submicrometer fibers under magnitudes of the key forming parameters to generate fibers via pressure spinning. The energy consumption, along with the fiber diameter, and production rate during the manufacture of fibers is predominantly attributed to the characteristics of polymeric solutions utilized

Latest developments in innovative manufacturing to combine nanotechnology with healthcare

Nanotechnology has become increasingly important in advancing the frontiers of many key areas of healthcare, for example, drug delivery and tissue engineering. To fully harness the many benefits of nanotechnology in healthcare, innovative manufacturing is necessary to mass produce nanoparticles and nanofibers, the two major types of nanofeatures currently sought after and of immense utilitarian value in healthcare. For example, nanoparticles are a key drug delivery enabler, the structural and mechanical mimicry are important attributes of nanofiber which are increasingly used as biomimetic agents

Current methodologies and approaches for the formation of core–sheath polymer fibers for biomedical applications

The application of polymer fibers has rocketed to unimaginable heights in recent years and occupies every corner of our day-to-day life, from knitted protective textile clothes to buzzing smartphone electronics. Polymer fibers could be obtained from natural and synthetic polymers at a length scale from the nanometer to micrometer range. These fibers could be formed into different configurations such as single, core–sheath, hollow, blended, or composite according to human needs. Of these several conformations of fibers, core–sheath polymer fibers are an interesting class of materials, which shows superior physical, chemical, and biological properties. In core–sheath fiber structures, one of the components called a core is fully surrounded by the second component known as a sheath. In this format, different polymers can be applied as a sheath over a solid core of another polymer, thus resulting in a variety of modified properties while maintaining the major fiber property. After a brief introduction to core–sheath fibers, this review paper focuses on the development of the electrospinning process to manufacture core–sheath fibers followed by illustrating the current methodology and approaches to form them on a larger scale, suitable for industrial manufacturing and exploitation. Finally, the paper reviews the applications of the core–sheath fibers, in particular, recent studies of core–sheath polymer fibers in tissue engineering (nerve, vascular grafts, cardiomyocytes, bone, tendons, sutures, and wound healing), growth factors and other bioactive component release, and drug delivery. Therefore, core–sheath structures are a revolutionary development in the field of science and technology, becoming a backbone to many emerging technologies and novel opportunities

The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease

Cardiovascular disease is the leading cause of death. The disease is due to atherosclerosis which is characterized by lipid and fat accumulation in arterial blood vessel walls. A key causative event is the accumulation of oxidised low density lipoprotein particles within vascular cells, and this is mediated by scavenger receptors. One such molecule is the LOX-1 scavenger receptor that is expressed on endothelial, vascular smooth muscle, and lymphoid cells including macrophages. LOX-1 interaction with OxLDL particles stimulates atherosclerosis. LOX-1 mediates OxLDL endocytosis via a clathrin-independent internalization pathway. Transgenic animal model studies show that LOX-1 plays a significant role in atherosclerotic plaque initiation and progression. Administration of LOX-1 antibodies in cellular and animal models suggest that such intervention inhibits atherosclerosis. Antiatherogenic strategies that target LOX-1 function using gene therapy or small molecule inhibitors would be new ways to address the increasing incidence of vascular disease in many countries

Novel pressurised gyration device for making core-sheath polymer fibres

Core-sheath fibres of two polymers were generated using a novel set-up where rotating speed and pressure can be varied at ambient temperature. The specially designed spinneret consists of inner and outer chambers which can accommodate two polymers and other additives. The new methodology was demonstrated using poly(ethylene oxide) and poly(methylmethacrylate) (PMMA). Dyes were used as colouring agents for the polymers to verify core-sheath formation, and optical, scanning and fluorescent microscopy of the formed fibres confirmed the presence of a core-sheath combination. The core diameter obtained was in the range 5–10 μm and the sheath fibre diameter was 20–30 μm. The core/sheath diameter can be pre-set by selecting the forming conditions. To show the flexibility of the new method, nanoparticle containing PMMA fibres were also produced using the new device and incorporation of the nanoparticles in the sheath and core of the fibres was verified by electron microscopy and energy-dispersive X-ray spectroscopy analysis. A high yield of fibre was obtained and with more severe forming conditions the size of core-sheath fibres generated can be reduced to the nanoscale. Thus, the new process has a real capability of manufacturing a wide variety of novel functional materials and structures in a single scalable set-up

Soft-Tipped Sensor with Compliance Control for Elasticity Sensing and Palpation

Stiffness sensing and palpation are essential for understanding object properties, including tissue health and fruit ripeness. Currently, there is limited research on using soft-tipped sensors for stiffness sensing and dynamic palpation. To address these challenges, we investigate how the pressure modulated optical tracking (PMOT) sensor can use compliance control to quantify tissue stiffness and detect margins in samples through dynamic palpation. Results show that the PMOT sensor modulus of elasticity sensing range is from 4.20 kPa up to 177.62 kPa. Across all untrained samples, elasticity was measured with a rootmean-square error (RMSE) of 7.72%. Further, it is shown that the sensor can locate margins between 13.4 kPa and embedded 29.3 kPa materials during palpation. When mounted on a linear rail, averaged for the direction of travel, the sensor’s signal-tonoise ratio (SNR) was up to 39.5:1. Participants used the sensor to locate embedded margins in a teleoperation environment with visual feedback. This was achieved with an accuracy of 96.5%

Co-Axial Gyro-Spinning of PCL/PVA/HA Core-Sheath Fibrous Scaffolds for Bone Tissue Engineering

The present study aspires towards fabricating core-sheath fibrous scaffolds by state-of-the-art pressurized gyration for bone tissue engineering applications. The core-sheath fibers comprising dual-phase poly-ε-caprolactone (PCL) core and polyvinyl alcohol (PVA) sheath are fabricated using a novel "co-axial" pressurized gyration method. Hydroxyapatite (HA) nanocrystals are embedded in the sheath of the fabricated scaffolds to improve the performance for application as a bone tissue regeneration material. The diameter of the fabricated fiber is 3.97 ± 1.31 µm for PCL-PVA/3%HA while pure PCL-PVA with no HA loading gives 3.03 ± 0.45 µm. Bead-free fiber morphology is ascertained for all sample groups. The chemistry, water contact angle and swelling behavior measurements of the fabricated core-sheath fibrous scaffolds indicate the suitability of the structures in cellular activities. Saos-2 bone osteosarcoma cells are employed to determine the biocompatibility of the scaffolds, wherein none of the scaffolds possess any cytotoxicity effect, while cell proliferation of 94% is obtained for PCL-PVA/5%HA fibers. The alkaline phosphatase activity results suggest the osteogenic activities on the scaffolds begin earlier than day 7. Overall, adaptations of co-axial pressurized gyration provides the flexibility to embed or encapsulate bioactive substances in core-sheath fiber assemblies and is a promising strategy for bone healing

Optical properties of tissue measured using terahertz pulsed imaging.

The first demonstrations of terahertz imaging in biomedicine were made several years ago, but few data are available on the optical properties of human tissue at terahertz frequencies. A catalogue of these properties has been established to estimate variability and determine the practicality of proposed medical applications in terms of penetration depth, image contrast and reflection at boundaries. A pulsed terahertz imaging system with a useful bandwidth 0.5-2.5 THz was used. Local ethical committee approval was obtained. Transmission measurements were made through tissue slices of thickness 0.08 to 1 mm, including tooth enamel and dentine, cortical bone, skin, adipose tissue and striated muscle. The mean and standard deviation for refractive index and linear attenuation coefficient, both broadband and as a function of frequency, were calculated. The measurements were used in simple models of the transmission, reflection and propagation of terahertz radiation in potential medical applications. Refractive indices ranged from 1.5 ± 0.5 for adipose tissue to 3.06 ± 0.09 for tooth enamel. Significant differences (P<0.05) were found between the broadband refractive indices of a number of tissues. Terahertz radiation is strongly absorbed in tissue so reflection imaging, which has lower penetration requirements than transmission, shows promise for dental or dermatological applications